Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance

被引:6
|
作者
Kim, Seon Young [1 ,2 ]
Im, Kyongok [3 ]
Park, Si Nae [3 ]
Kim, Jung-Ah [1 ]
Yoon, Sung-Soo [3 ,4 ]
Lee, Dong Soon [1 ,3 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Lab Med, 101 Daehak Ro, Seoul 110744, South Korea
[2] Chungnam Natl Univ, Coll Med, Dept Lab Med, Daejeon, South Korea
[3] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
基金
新加坡国家研究基金会;
关键词
AL amyloidosis; Monoclonal gammopathy of undermined significance; Multiple myeloma; Cytogenetics; IN-SITU HYBRIDIZATION; HIGH-DOSE MELPHALAN; MULTIPLE-MYELOMA; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; AL AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS; GENETIC EVENTS; TRANSPLANTATION; TRANSLOCATIONS;
D O I
10.1016/j.leukres.2016.03.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We performed cytoplasmic fluorescence in situ hybridization assays of light chain amyloidosis (AL). In total, 234 patients were enrolled: 28 patients with AL, 24 with monoclonal gammopathy of undetermined significance (MGUS), and 182 with multiple myeloma (MM). Chromosomal abnormalities were detected in 13 of 22 (59%) AL patients without MM. All 13 patients demonstrated IGH rearrangement, and t(11;14)1IGH-CCND1 was most frequent (32%). Chromosome gain was not observed in AL patients without MM. These findings were dissimilar to findings in MGUS patients, in whom trisomy 9 was the most frequent abnormality. Of 6 AL patients with MM, 5 (83%) patients had cytogenetic abnormalities: lq gain (4/6, 67%), gains of chromosome 9 (3/6, 50%), IGH rearrangement and RBI (13q) deletions (2/6 each, 33%). The percentage of clonal plasma cells among total plasma cells was variable (median, 75%; range, 16-100%) for AL patients without MM, which was lower than the results for MM patients (median 100%). The overall survival of AL patients without MM was not significantly different according to the presence of cytogenetic abnormalities (13= 0.510). In summary, among Korean AL patients, IGH rearrangement was the most frequent cytogenetic abnormality and cytogenetic aberration patterns differ compared with MGUS and MM patients. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [31] Gene expression profiling of clonal plasma cells in light chain (AL) amyloidosis by microarray analysis.
    Manske, MK
    Gonzalez-Paz, NC
    Ballman, KV
    Dispenzieri, A
    Price-Troska, TL
    Fonseca, R
    Abraham, RS
    BLOOD, 2003, 102 (11) : 369A - 369A
  • [32] Immunoglobulin Light Chain Amyloidosis (AL) and CS1 Expression in Bone Marrow Plasma Cells
    Ondrejka, Sarah L.
    Durkin, Lisa
    Rosenbaum, Cara
    Hsi, Eric
    LABORATORY INVESTIGATION, 2015, 95 : 370A - 370A
  • [33] Immunoglobulin Light Chain Amyloidosis (AL) and CS1 Expression in Bone Marrow Plasma Cells
    Ondrejka, Sarah L.
    Durkin, Lisa
    Rosenbaum, Cara
    Hsi, Eric
    MODERN PATHOLOGY, 2015, 28 : 370A - 370A
  • [34] Prognostic stratification and treatment of cardiac light chain amyloidosis: A narrow path in the jungle
    Potena, Luciano
    Quarta, Candida Cristina
    Grigioni, Francesco
    Rapezzi, Claudio
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (02): : 136 - 138
  • [35] The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis
    Dinner, Shira
    Witteles, Wesley
    Witteles, Ronald
    Lam, Anthony
    Arai, Sally
    Lafayette, Richard
    George, Tracy I.
    Schrier, Stanley L.
    Liedtke, Michaela
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 367 - 372
  • [36] Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
    Kim, Darae
    Choi, Jin-Oh
    Kim, Kihyun
    Kim, Seok Jin
    Kim, Jung-Sun
    Jeon, Eun-Seok
    ESC HEART FAILURE, 2021, 8 (06): : 5594 - 5599
  • [37] Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis
    Weiss, Brendan M.
    Wong, Sandy W.
    Comenzo, Raymond L.
    BLOOD, 2016, 127 (19) : 2275 - 2280
  • [38] Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis
    Zhao, Lei
    Li, Jian
    Tian, Zhuang
    Fang, Quan
    JOURNAL OF CARDIOLOGY, 2016, 68 (5-6) : 426 - 430
  • [39] Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis
    Cohen, Oliver C.
    Sathyanath, Ananth
    Petrie, Aviva
    Ravichandran, Sriram
    Law, Steven
    Manwani, Richa
    Foard, Darren
    Sachchithanantham, Sajitha
    Mahmood, Shameem
    Martinez-Naharro, Ana
    Fontana, Marianna
    Whelan, Carol J.
    Hawkins, Philip N.
    Lachmann, Helen J.
    Gillmore, Julian D.
    Wechalekar, Ashutosh D.
    HEART, 2022, 108 (20) : 1616 - 1622
  • [40] Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
    Kim, Darae
    Choi, Jin-Oh
    Kim, Kihyun
    Kim, Seok Jin
    Kim, Jung-Sun
    Jeon, Eun-Seok
    ESC HEART FAILURE, 2022, 8 (06): : 5594 - 5599